A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion(TM) (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee

Trial Profile

A Prospective Phase I/II Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion(TM) (4 ML) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the Knee

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms STRUT
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 03 Aug 2016 According to an Ampio Pharmaceuticals media release, this study was accepted for publication in the journal Orthopedics.
    • 22 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 25 Feb 2015 Top-line results published in an Ampio Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top